STEPHEN L. ZUCKERMAN, M.D. - Corporate Board Profile

Clearfield, Inc.

Filing Date	Source Excerpt
2006-07-06	Dr. Stephen L. Zuckerman served as a director of the Company from January 1986 through August 1991 and was reappointed to the Board in February 2002. The Company has an audit committee, a compensation committee, and a nominating committee, each of which is comprised of all non-employees (outside directors). The members of these committees during fiscal 2006 were as follows: Stephen Zuckerman. Each director who is not also an employee of the Company receives an annual director’s fee of $5,000.
2007-07-13	Dr. Stephen L. Zuckerman served as a director of the Company from January 1986 through August 1991 and was reappointed to the Board in February 2002. Dr. Zuckerman practices internal medicine at Aspen Medical Group East Lake Street Clinic, and in addition, has been actively involved for many years with developing companies in the high tech area. He served as chairman of the board of ProtaTek International Inc., a biotechnology company manufacturing for the human and veterinary marketplace (1984 to 1987), as co-founder and chairman of the board of Hypertension Diagnostic Inc., also a biotechnology company that has developed a methodology for early detection of blood vessel disorders (1988 to 1991), and as a member of the board of Biosensor Inc. (1989 to 1991) and Micromedics Inc. (1986 to 1991 and February 2002 to present). From 1982 to 1995 Dr. Zuckerman was president of M-T Venture Capital Fund, Inc., a Minnesota corporation created to invest in early-stage biotechnology and medical technology companies. Since 1976, Dr. Zuckerman has consulted in the health care delivery field, focusing his efforts on the regionalization of health care services. He was the designer, founder and director of the University of Minnesota Hospitals’ Outreach Program from 1976 to 1984. Besides his internal medicine practice, Dr. Zuckerman presently is chairman of the board of The Foundation for Rural Health Care, a nonprofit organization that owns and manages three rural nursing homes, and a member of the board of Micromedics, Inc. He is also president of M-T Venture Capital Fund II, Inc. and chairman of the board of The University Film Society, Minneapolis, Minnesota (2000 to present).
2008-01-24	Dr. Stephen L. Zuckerman served as a director of the Company from January 1986 through August 1991 and was reappointed to the Board in February 2002. Dr. Zuckerman has been actively involved for many years with developing companies in the high tech area. He served as chairman of the board of ProtaTek International Inc., a biotechnology company manufacturing for the human and veterinary marketplace (1984 to 1987), as co-founder and chairman of the board of Hypertension Diagnostic Inc., also a biotechnology company that has developed a methodology for early detection of blood vessel disorders (1988 to 1991), and as a member of the board of Biosensor Inc. (1989 to 1991) and Micromedics Inc. (1986 to 1991 and February 2002 to present). From 1982 to 1995 Dr. Zuckerman was president of M-T Venture Capital Fund, Inc., a Minnesota corporation created to invest in early-stage biotechnology and medical technology companies. Since 1976, Dr. Zuckerman has consulted in the health care delivery field, focusing his efforts on the regionalization of health care services. He was the designer, founder and director of the University of Minnesota Hospitals’ Outreach Program from 1976 to 1984. Besides his internal medicine practice, Dr. Zuckerman presently is chairman of the board of The Foundation for Rural Health Care, a nonprofit organization that owns and manages three rural nursing homes, and a member of the board of Micromedics, Inc. He is also president of M-T Venture Capital Fund II, Inc. and chairman of the board of Minnesota Film Arts, an organization created thru the merger of the University Film Society and the Oak Street Cinema, Minneapolis, Minnesota (2000 to present). Compensation table shows $5,000 fees earned or paid in cash and $1,558 option awards totaling $6,558.
2009-01-09	Dr. Stephen L. Zuckerman served as a director of the Company... The following table provides information on the compensation paid in fiscal 2008 to each of our non-employee directors... Stephen L. Zuckerman $2,500 Fees Earned or Paid in Cash, $2,463 Option Awards, Total $4,963.
2010-01-26	Dr. Zuckerman has been practicing physician since 1969. ... The current members of the Compensation Committee are Ronald G. Roth (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. The current members of the Nominating and Corporate Governance Committee are Donald R. Hayward (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. The Audit Committee presently consists of four directors: Charles N. Hayssen (Chair), Donald R. Hayward, John G. Reddan and Stephen L. Zuckerman M.D. The following table shows for fiscal year 2009, the cash and other compensation paid by us to each of our Board members: Stephen L. Zuckerman, M.D. $7,500 Fees Earned or Paid in Cash, $3,325 Option Awards, Total $10,825.
2011-01-11	Stephen L. Zuckerman, M.D., age 70, has served as our director since 2002. The current members of the Compensation Committee are Ronald G. Roth (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. The current members of the Nominating and Corporate Governance Committee are Donald R. Hayward (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. For services in our fiscal year 2010, each non-employee director received a retainer of $10,000 that was paid at the end of fiscal year 2010 and the chair of the Audit Committee received an additional retainer of $2,500. Stephen L. Zuckerman received $10,000 fees earned or paid in cash and $1,590 option awards for a total of $11,590.
2012-01-11	Stephen L. Zuckerman, M.D., age 71, has served as our director since 2002. The current members of the Compensation Committee are Ronald G. Roth (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. The current members of the Nominating and Corporate Governance Committee are Donald R. Hayward (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. For services in our fiscal year 2011, each non-employee director received a retainer of $10,000 that was paid in fiscal year 2011 and the chair of the Audit Committee received an additional retainer of $2,500. Stephen L. Zuckerman received $10,000 in fees and $8,647 in option awards for a total of $18,647.
2013-01-11	Stephen L. Zuckerman, M.D., age 72, has served as our director since 2002. The current members of the Compensation Committee are Ronald G. Roth (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. The current members of the Nominating and Corporate Governance Committee are Donald R. Hayward (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. For services in our fiscal year 2012, each non-employee director received a retainer of $10,000 that was paid in fiscal year 2012 and the chair of the Audit Committee received an additional retainer of $2,500. The following table shows for fiscal year 2012, the cash and other compensation paid by us to each of our Board members: Stephen L. Zuckerman, M.D. $10,000 fees earned or paid in cash, $8,896 option awards, total $18,896.
2014-01-10	Stephen L. Zuckerman, M.D., age 73, has served as our director since 2002. The current members of the Compensation Committee are Ronald G. Roth (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. The current members of the Nominating and Corporate Governance Committee are Donald R. Hayward (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. For services in our fiscal year 2013, each non-employee director received a retainer of $10,000 that was paid in fiscal year 2013. The following table shows for fiscal year 2013, the cash and other compensation paid by us to each of our Board members: Stephen L. Zuckerman, M.D. $10,000 fees earned or paid in cash, $9,999 restricted stock awards, total $19,999.
2015-01-09	Stephen L. Zuckerman, M.D., age 74, has served as our director since 2002. ... The current members of the Compensation Committee are Ronald G. Roth (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. ... The current members of the Nominating and Corporate Governance Committee are Donald R. Hayward (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. ... For services in our fiscal year 2014, each non-employee director received a retainer of $10,000 that was paid in fiscal year 2014 and the chair of the Audit Committee received an additional retainer of $2,500. ... The following table shows for fiscal year 2014, the cash and other compensation paid by us to each of our Board members: Stephen L. Zuckerman, M.D. $10,000 fees earned in cash, $9,992 restricted stock awards, total $19,992.
2016-01-15	Stephen L. Zuckerman, M.D. has served as our director. The current members of the Compensation Committee are Ronald G. Roth (Chair), Patrick Goepel, John G. Reddan and Stephen L. Zuckerman, M.D. The current members of the Nominating and Corporate Governance Committee are Donald R. Hayward (Chair), John G. Reddan and Stephen L. Zuckerman, M.D. For services in our fiscal year 2015, each non-employee director received a retainer of $10,000 that was paid in fiscal year 2015 and the chair of the Audit Committee received an additional retainer of $2,500. The following table shows for fiscal year 2015, the cash and other compensation paid by us to each of our Board members: Stephen L. Zuckerman, M.D. $10,000 Fees Earned or Paid in Cash, $9,989 Restricted Stock Awards, Total $19,989.